According to GlaxoSmithKline's latest financial reports the company's current earnings (TTM) are $6.58 B. In 2021 the company made an earning of $7.42 B a decrease over its 2020 earnings that were of $8.79 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2022 (TTM) | $6.58 B | -11.29% |
2021 | $7.42 B | -15.57% |
2020 | $8.79 B | 10.81% |
2019 | $7.93 B | 25.28% |
2018 | $6.33 B | 37.91% |
2017 | $4.59 B | 80.02% |
2016 | $2.55 B | -83.68% |
2015 | $15.63 B | 219.06% |
2014 | $4.89 B | -53.64% |
2013 | $10.56 B | -1.3% |
2012 | $10.70 B | -12.13% |
2011 | $12.18 B | 149.01% |
2010 | $4.89 B | -60.81% |
2009 | $12.48 B | 2.43% |
2008 | $12.19 B | -19.37% |
2007 | $15.12 B | 4.65% |
2006 | $14.44 B | 19.85% |
2005 | $12.05 B | 5.67% |
2004 | $11.40 B | 12.91% |
2003 | $10.10 B | 50.2% |
2002 | $6.72 B | -9.52% |
2001 | $7.43 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | $23.58 B | 258.17% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $34.92 B | 430.44% | ๐บ๐ธ USA |
![]() Sanofi SNY | $8.65 B | 31.43% | ๐ซ๐ท France |
![]() Merck MRK | $17.77 B | 170.00% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | $2.38 B | -63.79% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | -$1.34 B | -120.25% | ๐ฎ๐ฑ Israel |
![]() Dynavax Technologies
DVAX | $0.33 B | -94.93% | ๐บ๐ธ USA |